Abstract 1057: Combination of the KRASG12C inhibitor sotorasib with targeted agents improves anti-tumor efficacy in KRAS p.G12C cancer models

MLA

Victor J. Cee, et al. “Abstract 1057: Combination of the KRASG12C Inhibitor Sotorasib with Targeted Agents Improves Anti-Tumor Efficacy in KRAS p.G12C Cancer Models.” Cancer Research, vol. 81, July 2021, p. 1057. EBSCOhost, https://doi.org/10.1158/1538-7445.am2021-1057.

APA

Victor J. Cee, Alla Verlinsky, Anne Y. Saiki, Brian A. Lanman, Marwan Fakih, J. Russell Lipford, Tyler Holt, Patricia McElroy, Karen Rex, Ji-Rong Sun, Jude Canon, Tao Osgood, Upendra P. Dahal, & Bernd Bruenner. (2021). Abstract 1057: Combination of the KRASG12C inhibitor sotorasib with targeted agents improves anti-tumor efficacy in KRAS p.G12C cancer models. Cancer Research, 81, 1057. https://doi.org/10.1158/1538-7445.am2021-1057

Chicago

Victor J. Cee, Alla Verlinsky, Anne Y. Saiki, Brian A. Lanman, Marwan Fakih, J. Russell Lipford, Tyler Holt, et al. 2021. “Abstract 1057: Combination of the KRASG12C Inhibitor Sotorasib with Targeted Agents Improves Anti-Tumor Efficacy in KRAS p.G12C Cancer Models.” Cancer Research 81 (July): 1057. doi:10.1158/1538-7445.am2021-1057.